Armata Pharmaceuticals (ARMP) Restructuring Costs (2014 - 2026)
Armata Pharmaceuticals (ARMP) posted Restructuring Costs of $2.0 million for Q1 2026, down 11.54% sequentially from $2.3 million in Q4 2025, and up 8.05% YoY from $1.9 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Restructuring Costs (2014 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Restructuring Costs for 5 years, with the latest figure at $2.0 million in Q1 2026.
- Quarterly Restructuring Costs rose 8.05% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.7 million (down 2.49% YoY) and the FY2025 annual result came in at $7.5 million, down 8.93% from the prior year.
- Restructuring Costs declined to $2.0 million in Q1 2026 per ARMP's latest filing, from $2.3 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $2.3 million in Q4 2025 and troughed at $1.4 million in Q2 2025.
- A 3-year average of $2.0 million and a median of $2.0 million in 2024 frame the typical range for Restructuring Costs.
- The sharpest annual moves came in 2025 and 2026: Restructuring Costs declined 23.55% in 2025, then advanced 8.05% in 2026.
- Over 3 years, Restructuring Costs stood at $2.2 million in 2024, then rose by 4.43% to $2.3 million in 2025, then fell by 11.54% to $2.0 million in 2026.
- According to Business Quant data, Restructuring Costs over the past three periods registered $2.0 million, $2.3 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.19 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 1.87 Mn |
| Mar 31, 2024 | 2.24 Mn |
| Sep 30, 2015 | 289,000.00 |
| Dec 31, 2014 | 24,000.00 |